Source:http://linkedlifedata.com/resource/pubmed/id/10550366
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2000-2-14
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0017-8470
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
756-63
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading | |
pubmed:year |
1999
|
pubmed:articleTitle |
[Interleukin 1. Part 2: Mode of action and therapeutic possibilities].
|
pubmed:affiliation |
Klinik und Poliklinik für Dermatologie, Ludwig Boltzmann Institut der Westfälischen Wilhelms-Universität Münster.
|
pubmed:publicationType |
Journal Article,
Review
|